—While MRI can detect abnormal atrophy during preclinical Alzheimer’s disease, atrophy assessment should be tailored to the targeted disease stage and intended use. Structural magnetic resonance ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

As described by Sperling et al, [2] one commonly used model of AD is that many factors including age, genetics, the environment, and others combine to lead to the accumulation of amyloid β (Aβ) in the ...